دورية أكاديمية
أعرض في EDS

Evaluation of Ouabain's Tissue Distribution in C57/Black Mice Following Intraperitoneal Injection, Using Chromatography and Mass Spectrometry.

التفاصيل البيبلوغرافية
العنوان: Evaluation of Ouabain's Tissue Distribution in C57/Black Mice Following Intraperitoneal Injection, Using Chromatography and Mass Spectrometry.
المؤلفون: Abaimov DA; Research Center of Neurology, Volokolamskoye Shosse 80, 125367 Moscow, Russia., Kazanskaya RB; Research Center of Neurology, Volokolamskoye Shosse 80, 125367 Moscow, Russia.; Biological Department, Saint Petersburg State University, Universitetskaya Emb. 7/9, 199034 St. Petersburg, Russia., Ageldinov RA; Scientific Center for Biomedical Technologies of the Federal Biomedical Agency of Russia, 119435 Krasnogorsk, Russia., Nesterov MS; Scientific Center for Biomedical Technologies of the Federal Biomedical Agency of Russia, 119435 Krasnogorsk, Russia., Timoshina YA; Research Center of Neurology, Volokolamskoye Shosse 80, 125367 Moscow, Russia.; Biological Department, Lomonosov Moscow State University, Leninskiye Gory 1, 119991 Moscow, Russia., Platova AI; The Mental Health Research Center, Kashirskoye Shosse 34, 115522 Moscow, Russia., Aristova IJ; Biological Department, Saint Petersburg State University, Universitetskaya Emb. 7/9, 199034 St. Petersburg, Russia.; Institute of Translational Biomedicine, Saint Petersburg State University, Universitetskaya Emb. 7/9, 199034 St. Petersburg, Russia., Vinogradskaia IS; Non-State Private Educational Institution of Higher Professional Education, Moscow University for Industry and Finance 'Synergy', Meshchanskaya Street, 9/14, Building 1, 129090 Moscow, Russia., Fedorova TN; Research Center of Neurology, Volokolamskoye Shosse 80, 125367 Moscow, Russia., Volnova AB; Biological Department, Saint Petersburg State University, Universitetskaya Emb. 7/9, 199034 St. Petersburg, Russia.; Institute of Translational Biomedicine, Saint Petersburg State University, Universitetskaya Emb. 7/9, 199034 St. Petersburg, Russia., Gainetdinov RR; Institute of Translational Biomedicine, Saint Petersburg State University, Universitetskaya Emb. 7/9, 199034 St. Petersburg, Russia.; Saint-Petersburg University Hospital, 199034 St. Petersburg, Russia., Lopachev AV; Research Center of Neurology, Volokolamskoye Shosse 80, 125367 Moscow, Russia.; Institute of Translational Biomedicine, Saint Petersburg State University, Universitetskaya Emb. 7/9, 199034 St. Petersburg, Russia.
المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Apr 13; Vol. 25 (8). Date of Electronic Publication: 2024 Apr 13.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI, [2000-
مواضيع طبية MeSH: Ouabain* , Mice, Inbred C57BL*, Animals ; Tissue Distribution ; Injections, Intraperitoneal ; Mice ; Male ; Blood-Brain Barrier/metabolism ; Blood-Brain Barrier/drug effects ; Brain/metabolism ; Brain/drug effects ; Mass Spectrometry/methods ; Kidney/metabolism ; Kidney/drug effects ; Liver/metabolism ; Liver/drug effects ; Chromatography, High Pressure Liquid/methods ; Myocardium/metabolism ; Cardiotonic Agents/pharmacokinetics ; Cardiotonic Agents/pharmacology ; Cardiotonic Agents/administration & dosage
مستخلص: Cardiotonic steroids (CTSs), such as digoxin, are used for heart failure treatment. However, digoxin permeates the brain-blood barrier (BBB), affecting central nervous system (CNS) functions. Finding a CTS that does not pass through the BBB would increase CTSs' applicability in the clinic and decrease the risk of side effects on the CNS. This study aimed to investigate the tissue distribution of the CTS ouabain following intraperitoneal injection and whether ouabain passes through the BBB. After intraperitoneal injection (1.25 mg/kg), ouabain concentrations were measured at 5 min, 15 min, 30 min, 1 h, 3 h, 6 h, and 24 h using HPLC-MS in brain, heart, liver, and kidney tissues and blood plasma in C57/black mice. Ouabain was undetectable in the brain tissue. Plasma: C max = 882.88 ± 21.82 ng/g; T max = 0.08 ± 0.01 h; T 1/2 = 0.15 ± 0.02 h; MRT = 0.26 ± 0.01. Cardiac tissue: C max = 145.24 ± 44.03 ng/g (undetectable at 60 min); T max = 0.08 ± 0.02 h; T 1/2 = 0.23 ± 0.09 h; MRT = 0.38 ± 0.14 h. Kidney tissue: C max = 1072.3 ± 260.8 ng/g; T max = 0.35 ± 0.19 h; T 1/2 = 1.32 ± 0.76 h; MRT = 1.41 ± 0.71 h. Liver tissue: C max = 2558.0 ± 382.4 ng/g; T max = 0.35 ± 0.13 h; T 1/2 = 1.24 ± 0.7 h; MRT = 0.98 ± 0.33 h. Unlike digoxin, ouabain does not cross the BBB and is eliminated quicker from all the analyzed tissues, giving it a potential advantage over digoxin in systemic administration. However, the inability of ouabain to pass though the BBB necessitates intracerebral administration when used to investigate its effects on the CNS.
References: Cell Biosci. 2015 Nov 18;5:64. (PMID: 26587223)
Evid Based Complement Alternat Med. 2021 Sep 27;2021:2673183. (PMID: 34616474)
Arzneimittelforschung. 1971 Sep;21(9):1399-403. (PMID: 5171797)
Br J Pharmacol. 1977 Jan;59(1):101-6. (PMID: 836990)
Verh Dtsch Ges Kreislaufforsch. 1974;40:301-5. (PMID: 4450673)
Int J Mol Sci. 2021 Mar 27;22(7):. (PMID: 33801629)
Cell Biochem Funct. 2016 Jul;34(5):367-77. (PMID: 27338714)
Int J Psychiatry Med. 1977-1978;8(4):371-81. (PMID: 700928)
Am J Physiol. 1968 May;214(5):1048-53. (PMID: 5689599)
Heart Lung. 1993 Nov-Dec;22(6):477-81. (PMID: 8288449)
Pharmacol Rev. 2009 Mar;61(1):9-38. (PMID: 19325075)
Circ Res. 1976 Mar;38(3):185-91. (PMID: 1248066)
J Ethnopharmacol. 1993 Aug;39(3):161-6. (PMID: 8258972)
Cardiol Rev. 2003 Mar-Apr;11(2):73-93. (PMID: 12620132)
Acta Paediatr Scand. 1975 May;64(3):497-504. (PMID: 1155068)
Acta Physiol Scand Suppl. 1998 Aug;643:69-77. (PMID: 9789548)
J Pharmacol Exp Ther. 1946 Aug;87(4 Suppl):364-74. (PMID: 20279256)
Cell Calcium. 2020 Mar;86:102156. (PMID: 31896530)
Sci Rep. 2019 Oct 30;9(1):15627. (PMID: 31666560)
Dtsch Med Wochenschr. 1979 Jul 6;104(27):976-9. (PMID: 456272)
Circ Res. 1967 May;20(5):473-6. (PMID: 6057680)
J Pharm Sci. 1999 Dec;88(12):1281-7. (PMID: 10585223)
J Pharmacol Exp Ther. 1972 Dec;183(3):513-9. (PMID: 4636390)
Int J Sports Med. 2017 Apr;38(4):263-269. (PMID: 28219103)
Circulation. 1974 Jul;50(1):103-7. (PMID: 4835256)
J Clin Psychopharmacol. 1995 Feb;15(1):82-3. (PMID: 7714233)
J Med Chem. 2021 Jun 10;64(11):7045-7059. (PMID: 34010555)
Prog Neuropsychopharmacol Biol Psychiatry. 1995 Sep;19(5):955-62. (PMID: 8539431)
Eur Heart J Cardiovasc Pharmacother. 2022 Dec 2;8(8):756-767. (PMID: 34921603)
Pflugers Arch. 2019 Aug;471(8):1143-1157. (PMID: 31250095)
Circulation. 1972 Jun;45(6):1176-82. (PMID: 5032817)
معلومات مُعتمدة: 22-75-10131 Russian Science Foundation; 95444211 Saint-Petersburg State University
فهرسة مساهمة: Keywords: blood plasma; brain; brain–blood barrier; cardiac tissue; cardiotonic steroids; digoxin; kidney; liver; ouabain
المشرفين على المادة: 5ACL011P69 (Ouabain)
0 (Cardiotonic Agents)
تواريخ الأحداث: Date Created: 20240427 Date Completed: 20240427 Latest Revision: 20240429
رمز التحديث: 20240429
مُعرف محوري في PubMed: PMC11050293
DOI: 10.3390/ijms25084318
PMID: 38673903
قاعدة البيانات: MEDLINE
الوصف
تدمد:1422-0067
DOI:10.3390/ijms25084318